<div class="container">

<table style="width: 100%;"><tr>
<td>TRRT.RTTR</td>
<td style="text-align: right;">R Documentation</td>
</tr></table>
<h2>
Reference Datasets for TRRT|RTTR Replicate Designs
</h2>

<h3>Description</h3>

<p>Datasets from the public domain to be evaluated by <code>method.A()</code>, <code>method.B()</code>, or <code>ABE()</code>.
</p>


<h3>Format</h3>


<ul>
<li>
<p> Reference Dataset 05<br>
26 subjects.<br>
Balanced (13 subjects in both sequences) and complete. No outliers.<br>
A data frame with 104 observations on the following 5 variables:
</p>

<dl>
<dt>rds05</dt>
<dd>

<table>
<tr>
<td style="text-align: left;">
              <code>subject</code> </td>
<td style="text-align: left;"> a factor with 26 levels: 1, 2, ..., 26</td>
</tr>
<tr>
<td style="text-align: left;">
              <code>period</code> </td>
<td style="text-align: left;"> a factor with 4 levels: 1, 2, 3, 4</td>
</tr>
<tr>
<td style="text-align: left;">
              <code>sequence</code> </td>
<td style="text-align: left;"> a factor with 2 levels: TRRT, RTTR</td>
</tr>
<tr>
<td style="text-align: left;">
              <code>treatment</code> </td>
<td style="text-align: left;"> a factor with 2 levels: T, R</td>
</tr>
<tr>
<td style="text-align: left;">
              <code>PK</code> </td>
<td style="text-align: left;"> a numeric vector of pharmacokinetic responses (here C<sub>max</sub>)
            </td>
</tr>
</table>
</dd>
</dl>
<p>In the source evaluated by <abbr><span class="acronym">SAS</span></abbr> with the <abbr><span class="acronym">FDA</span></abbr>’s mixed effects model (termed ‘Method C’ by the <abbr><span class="acronym">EMA</span></abbr>; not compatible with the guideline). Reported results:
</p>
<dl>
<dt>SAS Proc Mixed</dt>
<dd>

<table>
<tr>
<td style="text-align: left;">
              <code>CVwR</code> </td>
<td style="text-align: left;"> 5.47%</td>
</tr>
<tr>
<td style="text-align: left;">
              <code>CVwT</code> </td>
<td style="text-align: left;"> 6.75%</td>
</tr>
<tr>
<td style="text-align: left;">
              <code>PE</code> </td>
<td style="text-align: left;"> 107.90%</td>
</tr>
<tr>
<td style="text-align: left;">
              <code>90% CI</code> </td>
<td style="text-align: left;"> 103.66% – 112.2%
            </td>
</tr>
</table>
</dd>
</dl>
</li>
<li>
<p> Reference Dataset 11<br>
37 subjects.<br>
Unbalanced (18 subjects in sequence TRRT and 19 subjects in RTTR) and complete. No outliers.<br>
A data frame with 148 observations on the following 5 variables
</p>

<dl>
<dt>rds11</dt>
<dd>

<table>
<tr>
<td style="text-align: left;">
              <code>subject</code> </td>
<td style="text-align: left;"> a factor with 37 levels: 1, 2, ..., 37</td>
</tr>
<tr>
<td style="text-align: left;">
              <code>period</code> </td>
<td style="text-align: left;"> a factor with 4 levels: 1, 2, 3, 4</td>
</tr>
<tr>
<td style="text-align: left;">
              <code>sequence</code> </td>
<td style="text-align: left;"> a factor with 2 levels: TRRT, RTTR</td>
</tr>
<tr>
<td style="text-align: left;">
              <code>treatment</code> </td>
<td style="text-align: left;"> a factor with 2 levels: T, R</td>
</tr>
<tr>
<td style="text-align: left;">
              <code>PK</code> </td>
<td style="text-align: left;"> a numeric vector of pharmacokinetic responses (here C<sub>max</sub>)
            </td>
</tr>
</table>
</dd>
</dl>
<p>In the source evaluated by <abbr><span class="acronym">SAS</span></abbr> with the <abbr><span class="acronym">FDA</span></abbr>’s mixed effects model (termed ‘Method C’ by the <abbr><span class="acronym">EMA</span></abbr>; not compatible with the guideline). Reported results:
</p>
<dl>
<dt>SAS Proc MIXED</dt>
<dd>

<table>
<tr>
<td style="text-align: left;">
              <code>PE</code> </td>
<td style="text-align: left;"> 90.0%</td>
</tr>
<tr>
<td style="text-align: left;">
              <code>90% CI</code> </td>
<td style="text-align: left;"> 79.6% – 101.7%
            </td>
</tr>
</table>
</dd>
</dl>
</li>
<li>
<p> Reference Dataset 16<br>
38 subjects.<br>
Unbalanced (18 subjects in sequence TRRT and 20 in RTTR) and complete. No outliers.<br>
A data frame with 152 observations on the following 5 variables:
</p>

<dl>
<dt>rds16</dt>
<dd>

<table>
<tr>
<td style="text-align: left;">
              <code>subject</code> </td>
<td style="text-align: left;"> a factor with 38 levels: 1, 2, ..., 38</td>
</tr>
<tr>
<td style="text-align: left;">
              <code>period</code> </td>
<td style="text-align: left;"> a factor with 4 levels: 1, 2, 3, 4</td>
</tr>
<tr>
<td style="text-align: left;">
              <code>sequence</code> </td>
<td style="text-align: left;"> a factor with 2 levels: TRRT, RTTR</td>
</tr>
<tr>
<td style="text-align: left;">
              <code>treatment</code> </td>
<td style="text-align: left;"> a factor with 2 levels: T, R</td>
</tr>
<tr>
<td style="text-align: left;">
              <code>PK</code> </td>
<td style="text-align: left;"> a numeric vector of pharmacokinetic responses (here C<sub>max</sub>)
            </td>
</tr>
</table>
</dd>
</dl>
</li>
</ul>
<h3>Details</h3>


<table>
<tr>
<td style="text-align: center;">
    Dataset </td>
<td style="text-align: right;"> N </td>
<td style="text-align: center;"> CV<sub>wR</sub> (%) </td>
<td style="text-align: left;"> Evaluation</td>
</tr>
<tr>
<td style="text-align: center;">
    <code>rds05</code> </td>
<td style="text-align: right;"> 26 </td>
<td style="text-align: center;"> &lt;30 </td>
<td style="text-align: left;"> <code>method.A()</code>, <code>method.B()</code>, <code>ABE()</code>
</td>
</tr>
<tr>
<td style="text-align: center;">
    <code>rds11</code> </td>
<td style="text-align: right;"> 37 </td>
<td style="text-align: center;"> &gt;30 </td>
<td style="text-align: left;"> <code>method.A()</code>, <code>method.B()</code>
</td>
</tr>
<tr>
<td style="text-align: center;">
    <code>rds16</code> </td>
<td style="text-align: right;"> 38 </td>
<td style="text-align: center;"> &gt;30 </td>
<td style="text-align: left;"> <code>method.A()</code>, <code>method.B()</code>
  </td>
</tr>
</table>
<h3>Note</h3>

<p>In software sequences and treatments are ranked in lexical order. Hence, executing <code>str()</code> or <code>summary()</code> will show <code>sequence</code> as <code>"RTTR", "TRRT"</code> and <code>treatment</code> as <code>"R", "T"</code>. In <abbr><span class="acronym">BE</span></abbr> – by convention – sequences are ordered with <code>T</code> first. The package follows this convention.
</p>


<h3>Source</h3>


<table>
<tr>
<td style="text-align: center;">
    Dataset </td>
<td style="text-align: left;"> Origin </td>
<td style="text-align: left;"> Description</td>
</tr>
<tr>
<td style="text-align: center;">
    <code>rds05</code> </td>
<td style="text-align: left;"> Shumaker &amp; Metzler </td>
<td style="text-align: left;"> C<sub>max</sub> data given in the Appendix.</td>
</tr>
<tr>
<td style="text-align: center;">
    <code>rds11</code> </td>
<td style="text-align: left;"> Hauschke <em>et al.</em> </td>
<td style="text-align: left;"> C<sub>max</sub> data given in Table 9.6.</td>
</tr>
<tr>
<td style="text-align: center;">
    <code>rds16</code> </td>
<td style="text-align: left;"> FDA, CDER </td>
<td style="text-align: left;"> C<sub>max</sub> data of Drug 14a.
  </td>
</tr>
</table>
<h3>References</h3>

<p>Shumaker RC, Metzler CM. <em>The Phenytoin Trial is a Case Study of ‘Individual’ Bioequivalence.</em> Drug Inf J. 1998; 32(4): 1063–72. <a href="https://doi.org/10.1177/009286159803200426">doi:10.1177/009286159803200426</a>
</p>
<p>Hauschke D, Steinijans VW, Pigeot I. <em>Bioequivalence Studies in Drug Development.</em> Chichester: John Wiley; 2007. p216.
</p>
<p><abbr><span class="acronym">U.S.</span></abbr> Food and Drug Administration, Center for Drug Evaluation and Research. <em>Bioequivalence Studies.</em> Rockville, 1997. <a href="https://web.archive.org/web/20170723175533/https://www.fda.gov/downloads/Drugs/ScienceResearch/UCM301481.zip">bioequivalence study files</a> (archived 2017-07-23)
</p>


<h3>Examples</h3>

<pre><code class="language-R">str(rds05)
summary(rds05[2:5])
head(rds11, 8)
</code></pre>


</div>